PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Laboratory Medicine, University of Washington School of Medicine, Seattle, Washington, USA.\', \'Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.\', \'Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.\', \'Department of Biomedical Informatics and Medical Education, University of Washington School of Medicine, Seattle, Washington, USA.\', \'Department of Laboratory Medicine, University of Washington School of Medicine, Seattle, Washington, USA agrening@uw.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • e00941-2010.1128/JCM.00941-20
?:doi
?:hasPublicationType
?:journal
  • Journal of clinical microbiology
is ?:pmid of
?:pmid
?:pmid
  • 32381641
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.256
?:rankingScore_hIndex
  • 226
?:title
  • Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32381641>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32381641>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all